Atlas Trials

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Clinical trial NCT00095030 · COMPLETED

Trial details

NCT number
NCT00095030
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2004-02-01
Primary completion
2006-03-01
Enrollment
1752

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.